| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/06/2009 | WO2008138131A9 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 08/06/2009 | WO2008109532A8 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 08/06/2009 | WO2008109382A8 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof |
| 08/06/2009 | WO2008036675A8 Compositions and methods of enhancing immune responses |
| 08/06/2009 | WO2007115201A8 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 08/06/2009 | WO2005091925A8 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/06/2009 | WO2004031201A3 Systems and methods for selection and design of short interfering rna |
| 08/06/2009 | WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 08/06/2009 | WO2002051982A3 Bacterial promoters and methods of use |
| 08/06/2009 | WO2000015839A9 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin d receptor gene |
| 08/06/2009 | US20090199313 Non-mevalonate isoprenoid pathway |
| 08/06/2009 | US20090199311 Methods and means for producing hyaluronan |
| 08/06/2009 | US20090199310 Promotor of Hot Pepper Which is Related to TMV-Resistance |
| 08/06/2009 | US20090199307 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090198047 2'-Modified Oligonucleotides |
| 08/06/2009 | US20090198044 Anti-psgl-1 antibodies |
| 08/06/2009 | US20090197937 Marine actinomycete taxon for drug and fermentation product discovery |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197776 Liquid Tissue Preparation From Histopathologically Processed Biological Samples, Tissues and Cells |
| 08/06/2009 | US20090197346 Compositions and methods for preserving rna in biological samples |
| 08/06/2009 | US20090197339 In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris |
| 08/06/2009 | US20090197338 Method of Increasing the Function of an AAV Vector |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197336 Suppression of polymorphic alleles |
| 08/06/2009 | US20090197335 Method for improved transfer of dna into living cells by electroporation |
| 08/06/2009 | US20090197332 Modified Short Interfering RNA |
| 08/06/2009 | US20090197323 Identification and characterization of a novel alpha-amylase from maize endosperm |
| 08/06/2009 | US20090197320 Ancestral dengue virus envelope protein |
| 08/06/2009 | US20090197319 Virus-Like Particle Containing A Dengue Recombinant Replicon |
| 08/06/2009 | US20090197317 TSG-Like Gene |
| 08/06/2009 | US20090197307 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 08/06/2009 | US20090197304 Corynephage integrase-based site-specific insertion vector system |
| 08/06/2009 | US20090197303 Process for producing dipeptides |
| 08/06/2009 | US20090197301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/06/2009 | US20090197278 Antibodies to hADA2 |
| 08/06/2009 | US20090197273 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 08/06/2009 | US20090197269 Translocation and mutant CSF1R Kinase in human leukemia |
| 08/06/2009 | US20090197252 Detection of Mutations |
| 08/06/2009 | US20090197244 Method for typing and detecting HBV |
| 08/06/2009 | US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196884 Malaria Vaccines |
| 08/06/2009 | US20090196883 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2714292A1 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 08/06/2009 | CA2713746A1 System and method for large-scale infiltration of plants |
| 08/06/2009 | CA2713469A1 Methods and compositions relating to carcinoma stem cells |
| 08/06/2009 | CA2713458A1 Methods and compositions capable of causing post-transcriptional silencing of gene expression in a synergic manner |
| 08/06/2009 | CA2713338A1 Recombinant virus production using mammalian cells in suspension |
| 08/06/2009 | CA2713313A1 Methods and apparatus for particle introduction and recovery |
| 08/06/2009 | CA2713075A1 Cationic sirnas, synthesis and use for interfering rna |
| 08/06/2009 | CA2713065A1 Plants having altered growth and/or development and a method for making the same |
| 08/06/2009 | CA2712722A1 Isolated alcohol dehydrogenase enzymes and uses thereof |
| 08/06/2009 | CA2712634A1 Methods and compositions using klotho-fgf fusion polypeptides |
| 08/06/2009 | CA2712605A1 Monoclonal antibodies for ebola and marburg viruses |
| 08/06/2009 | CA2712336A1 Plants having increased yield-related traits and a method for making the same |
| 08/06/2009 | CA2711635A1 Wound healing compositions and treatments |
| 08/06/2009 | CA2710534A1 Nucleic acids of formula(1)(nugixmgnnv)a and derivatives thereof as an immunostimulating agent /adjuvant |
| 08/05/2009 | EP2085487A1 Method for proving cytosine methylations in immobilised DNA samples |
| 08/05/2009 | EP2085484A1 Method for identification of compound having antianxiety effect |
| 08/05/2009 | EP2085482A1 Nucleotide sequences which code for the metY gene |
| 08/05/2009 | EP2085481A1 System and method for large-scale infiltration of plants |
| 08/05/2009 | EP2085480A1 Use of the ocp3 mutation to regulate drought resistance in plants |
| 08/05/2009 | EP2085479A1 Reverse genetics of negative-strand rna viruses in yeast |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085477A1 A method for improving plant transformation efficiency by adding copper ion |
| 08/05/2009 | EP2085476A1 Method of enabling stable expression of transgene |
| 08/05/2009 | EP2085475A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 08/05/2009 | EP2085474A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/05/2009 | EP2085473A1 Auxiliary reagent for gene transfer |
| 08/05/2009 | EP2085472A1 D-serine dehydratase and use thereof |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085470A1 FVII or FVIIa variants |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2084540A2 Methods of treating, diagnosing or detecting cancer |
| 08/05/2009 | EP2084529A2 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
| 08/05/2009 | EP2084293A2 Genetically engineered biological indicator |
| 08/05/2009 | EP2084285A2 Co-expression of proline hydroxylases to facilitate hyp-glycosylation of proteins expressed and secreted in plant cells |
| 08/05/2009 | EP2084284A1 Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same |
| 08/05/2009 | EP2084283A1 Mutant dna polymerases and their genes |
| 08/05/2009 | EP2084282A2 Uncoupling of dna insert propagation and expression of protein for phage display |
| 08/05/2009 | EP2084281A1 Method for detecting nucleotide variations |
| 08/05/2009 | EP2084280A1 Integrated microfluidic component for purifying analyte molecules and purification method |
| 08/05/2009 | EP2084279A2 Dna-guided nanoparticle assemblies |
| 08/05/2009 | EP2084278A1 Nucleic acid promoter sequences that control gene expression in plants |
| 08/05/2009 | EP2084277A2 Ph sensitive liposome composition |
| 08/05/2009 | EP2084276A1 New tetracycline-sensitive bifidobacteria strains |
| 08/05/2009 | EP2084275A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 08/05/2009 | EP2084274A2 Modified coagulation factor ix polypeptides and use thereof for treatment |
| 08/05/2009 | EP2084273A1 Multiple mutation variants of serine protease |
| 08/05/2009 | EP2084185A2 Human antibodies neutralizing human metapneumovirus |
| 08/05/2009 | EP2084184A1 ILT-2 (LIRl ) VARIANTS WITH INCREASED AFFINITY FOR MHC CLASS I MOLECULES |
| 08/05/2009 | EP2084179A2 Method for making activated carboxypeptidases |
| 08/05/2009 | EP2083846A2 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 08/05/2009 | EP2083845A2 Ablative immunotherapy |